|
|
|
Insider
Information: |
St Peter Steven |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
721,630 |
|
Indirect Shares
|
3,377,476 |
|
|
Direct
Value |
$4,183,882 |
|
|
Indirect Value
|
$101,840,588 |
|
|
Total
Shares |
4,099,106 |
|
|
Total
Value |
$106,024,470 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Pacira Pharmaceuticals, Inc. |
PCRX |
10% Owner |
2011-11-21 |
0 |
2011-11-21 |
3,290,479 |
Premium* |
|
Aratana Therapeutics, Inc. |
PETX |
PRESIDENT AND CEO, Dir... |
2018-12-17 |
516,626 |
2018-12-17 |
86,997 |
Premium* |
|
Altimmune, Inc |
ALT |
Director |
2017-01-04 |
205,004 |
2015-03-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
|
2017-10-02 |
4 |
AS |
$6.24 |
$312,115 |
D/D |
(50,000) |
579,359 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
|
2017-11-10 |
4 |
AS |
$7.00 |
$350,000 |
D/D |
(50,000) |
529,359 |
0 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2017-01-04 |
4 |
OE |
$2.20 |
$181,500 |
D/D |
70,000 |
205,004 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
|
2015-01-13 |
4 |
AS |
$19.23 |
$1,442,408 |
D/D |
(75,000) |
609,394 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
|
2016-06-16 |
4 |
AS |
$6.24 |
$468,293 |
D/D |
(75,000) |
717,793 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
|
2018-09-21 |
4 |
AS |
$6.06 |
$454,305 |
D/D |
(75,000) |
574,233 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
|
2015-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
85,900 |
695,294 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
|
2016-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
97,500 |
792,793 |
0 |
- |
|
ALT |
Altimmune, Inc |
Director |
|
2016-09-16 |
4 |
OE |
$1.45 |
$175,907 |
D/D |
110,004 |
135,004 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
|
2018-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
135,600 |
691,626 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
|
2017-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
139,900 |
682,693 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
|
2014-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
225,000 |
754,191 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
10% Owner |
|
2011-11-21 |
4 |
B |
$6.50 |
$2,999,997 |
I/I |
461,538 |
3,290,479 |
1.5 |
- |
|
38 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|